Latest News for: cnd

Edit

CND Life Sciences to Present Updates from Three Clinical Trials Involving Their Skin Biopsy Diagnostic ...

Montana Standard 28 Mar 2025
Two studies track changes in cutaneous phosphorylated alpha-synuclein (P-SYN) in patients with dementia with Lewy bodies (DLB); the other determines the optimal number of skin biopsies necessary for accurate detection of P-SYN ... .
Edit

CND Life Sciences to Present Updates from Three Clinical Trials Involving Their Skin Biopsy Diagnostic Tool for Dementia and Other Related Disorders at the American Academy of Neurology 2025 Annual Meeting

PR Newswire 27 Mar 2025
SCOTTSDALE, Ariz., March 27, 2025 /PRNewswire/ -- CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker ...
  • 1
×